Intratumor Heterogeneity in Breast Cancer
- 18 March 2016
- book chapter
- research article
- Published by Springer Science and Business Media LLC
- Vol. 882, 169-189
- https://doi.org/10.1007/978-3-319-22909-6_7
Abstract
Intratumor heterogeneity is the main obstacle to effective cancer treatment and personalized medicine. Both genetic and epigenetic sources of intratumor heterogeneity are well recognized and several technologies have been developed for their characterization. With the technological advances in recent years, investigators are now elucidating intratumor heterogeneity at the single cell level and in situ. However, translating the accumulated knowledge about intratumor heterogeneity to clinical practice has been slow. We are certain that better understanding of the composition and evolution of tumors during disease progression and treatment will improve cancer diagnosis and the design of therapies. Here we review some of the most important considerations related to intratumor heterogeneity. We discuss both genetic and epigenetic sources of intratumor heterogeneity and review experimental approaches that are commonly used to quantify it. We also discuss the impact of intratumor heterogeneity on cancer diagnosis and treatment and share our perspectives on the future of this field.Keywords
This publication has 86 references indexed in Scilit:
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroupsNature, 2012
- Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistanceDrug Resistance Updates, 2012
- Distant metastasis occurs late during the genetic evolution of pancreatic cancerNature, 2010
- Genome remodelling in a basal-like breast cancer metastasis and xenograftNature, 2010
- Variability in gene expression underlies incomplete penetranceNature, 2010
- Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosisNature, 2009
- Circulating mutant DNA to assess tumor dynamicsNature Medicine, 2008
- DNA methylation and gene silencing in cancerNature Clinical Practice Oncology, 2005
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997